Home/Filings/4/0000721371-18-000027
4//SEC Filing

Giacomin Jon L 4

Accession 0000721371-18-000027

CIK 0000721371other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 5:54 PM ET

Size

8.1 KB

Accession

0000721371-18-000027

Insider Transaction Report

Form 4
Period: 2018-02-15
Giacomin Jon L
CEO, Pharmaceutical Segment
Transactions
  • Award

    Common Shares

    2018-02-15+14,68463,043 total
  • Sale

    Common Shares

    2018-02-20$68.65/sh5,724$392,95357,319 total
  • Sale

    Common Shares

    2018-02-20$69.12/sh2,271$156,97255,048 total
Footnotes (3)
  • [F1]Grant of restricted share units that vest on February 15, 2019.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.01 to $69.00, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3 to this Form 4.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.03 to $69.20, inclusive.

Issuer

CARDINAL HEALTH INC

CIK 0000721371

Entity typeother

Related Parties

1
  • filerCIK 0001623254

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:54 PM ET
Size
8.1 KB